Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thrombelastography | 8 | 2024 | 193 | 2.900 |
Why?
|
Cardiac Surgical Procedures | 12 | 2024 | 3674 | 1.800 |
Why?
|
Postoperative Hemorrhage | 4 | 2024 | 413 | 1.430 |
Why?
|
Thrombosis | 9 | 2022 | 2949 | 1.330 |
Why?
|
Blood Coagulation Tests | 4 | 2019 | 263 | 1.120 |
Why?
|
Thrombophilia | 4 | 2021 | 308 | 0.950 |
Why?
|
Platelet Transfusion | 2 | 2024 | 296 | 0.870 |
Why?
|
Protamines | 2 | 2021 | 110 | 0.760 |
Why?
|
Microfluidic Analytical Techniques | 2 | 2017 | 788 | 0.640 |
Why?
|
Platelet Function Tests | 3 | 2019 | 275 | 0.630 |
Why?
|
Heart Defects, Congenital | 8 | 2022 | 4698 | 0.580 |
Why?
|
Enzyme Assays | 1 | 2017 | 102 | 0.550 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2020 | 580 | 0.540 |
Why?
|
Cardiopulmonary Bypass | 5 | 2022 | 1090 | 0.510 |
Why?
|
Platelet Aggregation | 2 | 2017 | 769 | 0.470 |
Why?
|
Aspirin | 3 | 2021 | 3135 | 0.470 |
Why?
|
Blood Coagulation Disorders | 1 | 2017 | 349 | 0.460 |
Why?
|
Blood Coagulation | 4 | 2021 | 1166 | 0.390 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1084 | 0.390 |
Why?
|
Ventricular Function | 1 | 2013 | 403 | 0.370 |
Why?
|
Tissue Engineering | 4 | 2018 | 1855 | 0.370 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2020 | 2771 | 0.330 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2021 | 1480 | 0.330 |
Why?
|
Tissue Scaffolds | 3 | 2014 | 934 | 0.320 |
Why?
|
Secondary Prevention | 1 | 2015 | 1472 | 0.310 |
Why?
|
Aorta, Thoracic | 1 | 2015 | 1103 | 0.310 |
Why?
|
Drug Resistance | 1 | 2014 | 1591 | 0.300 |
Why?
|
Postoperative Complications | 6 | 2022 | 15749 | 0.290 |
Why?
|
Hepatocyte Growth Factor | 1 | 2009 | 268 | 0.280 |
Why?
|
Extracellular Matrix | 2 | 2014 | 1727 | 0.280 |
Why?
|
Infant | 12 | 2024 | 36363 | 0.270 |
Why?
|
Body Weight | 1 | 2017 | 4624 | 0.260 |
Why?
|
Pulmonary Artery | 1 | 2015 | 1935 | 0.260 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3805 | 0.250 |
Why?
|
Capillary Permeability | 1 | 2009 | 767 | 0.250 |
Why?
|
Stem Cells | 3 | 2020 | 3539 | 0.230 |
Why?
|
Hospital Mortality | 1 | 2018 | 5343 | 0.220 |
Why?
|
Bone Marrow Cells | 1 | 2011 | 2412 | 0.220 |
Why?
|
Antibodies, Anticardiolipin | 2 | 2013 | 62 | 0.210 |
Why?
|
Blood Transfusion | 3 | 2022 | 1295 | 0.210 |
Why?
|
Retrospective Studies | 12 | 2024 | 81457 | 0.210 |
Why?
|
Stem Cell Transplantation | 1 | 2011 | 1601 | 0.200 |
Why?
|
Rewarming | 1 | 2021 | 63 | 0.180 |
Why?
|
Shock, Hemorrhagic | 1 | 2022 | 224 | 0.180 |
Why?
|
Intraoperative Care | 1 | 2024 | 760 | 0.180 |
Why?
|
Partial Thromboplastin Time | 1 | 2021 | 202 | 0.170 |
Why?
|
Child, Preschool | 7 | 2024 | 42468 | 0.170 |
Why?
|
Child | 9 | 2024 | 80499 | 0.170 |
Why?
|
Preoperative Care | 2 | 2018 | 2266 | 0.150 |
Why?
|
Fibrinogen | 1 | 2022 | 896 | 0.150 |
Why?
|
Trophoblasts | 1 | 2020 | 223 | 0.150 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2009 | 3504 | 0.150 |
Why?
|
Acoustics | 1 | 2019 | 235 | 0.150 |
Why?
|
Limit of Detection | 1 | 2017 | 272 | 0.140 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2021 | 622 | 0.130 |
Why?
|
Tyrosine | 1 | 2020 | 1427 | 0.130 |
Why?
|
Humans | 31 | 2024 | 765734 | 0.120 |
Why?
|
Chemoprevention | 1 | 2017 | 327 | 0.120 |
Why?
|
Mesenchymal Stem Cells | 2 | 2018 | 1663 | 0.120 |
Why?
|
Gene Expression Regulation | 2 | 2014 | 11888 | 0.110 |
Why?
|
Plasminogen Inactivators | 1 | 2013 | 37 | 0.110 |
Why?
|
Heparin | 2 | 2019 | 1630 | 0.110 |
Why?
|
von Willebrand Factor | 1 | 2017 | 676 | 0.110 |
Why?
|
Reproducibility of Results | 4 | 2019 | 20120 | 0.110 |
Why?
|
Protein S | 1 | 2012 | 29 | 0.100 |
Why?
|
Point-of-Care Systems | 1 | 2022 | 1217 | 0.100 |
Why?
|
beta 2-Glycoprotein I | 1 | 2012 | 27 | 0.100 |
Why?
|
Infant, Newborn | 7 | 2022 | 26332 | 0.100 |
Why?
|
Antithrombin III | 1 | 2012 | 128 | 0.100 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2019 | 1094 | 0.100 |
Why?
|
Protein C | 1 | 2012 | 134 | 0.100 |
Why?
|
Automation, Laboratory | 1 | 2012 | 102 | 0.100 |
Why?
|
Treatment Outcome | 5 | 2022 | 65180 | 0.100 |
Why?
|
Fibrin | 1 | 2014 | 514 | 0.100 |
Why?
|
Anastomosis, Surgical | 1 | 2015 | 990 | 0.090 |
Why?
|
Female | 17 | 2024 | 395961 | 0.090 |
Why?
|
Blood Coagulation Factors | 1 | 2013 | 371 | 0.090 |
Why?
|
Thrombin | 1 | 2013 | 602 | 0.090 |
Why?
|
Risk Assessment | 3 | 2018 | 24279 | 0.090 |
Why?
|
Diabetes Mellitus | 1 | 2009 | 5891 | 0.090 |
Why?
|
Factor VIII | 1 | 2012 | 347 | 0.090 |
Why?
|
ROC Curve | 2 | 2019 | 3618 | 0.090 |
Why?
|
Infusions, Intravenous | 1 | 2015 | 2229 | 0.090 |
Why?
|
Male | 14 | 2024 | 363585 | 0.090 |
Why?
|
Calibration | 1 | 2012 | 814 | 0.080 |
Why?
|
Regeneration | 1 | 2018 | 1517 | 0.080 |
Why?
|
Perioperative Care | 1 | 2017 | 1055 | 0.080 |
Why?
|
Placenta | 1 | 2018 | 1728 | 0.080 |
Why?
|
Hospitals, Pediatric | 1 | 2018 | 1845 | 0.080 |
Why?
|
Hemorrhage | 1 | 2021 | 3461 | 0.080 |
Why?
|
CREB-Binding Protein | 1 | 2009 | 146 | 0.080 |
Why?
|
E1A-Associated p300 Protein | 1 | 2009 | 124 | 0.080 |
Why?
|
Alkaline Phosphatase | 1 | 2011 | 855 | 0.070 |
Why?
|
Dendritic Cells | 3 | 2004 | 2746 | 0.070 |
Why?
|
Linear Models | 1 | 2017 | 5876 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6499 | 0.070 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2012 | 701 | 0.070 |
Why?
|
Blotting, Western | 2 | 2012 | 5019 | 0.070 |
Why?
|
Adolescent | 5 | 2024 | 88781 | 0.070 |
Why?
|
Immunohistochemistry | 1 | 2020 | 11007 | 0.070 |
Why?
|
Stress, Mechanical | 1 | 2011 | 1669 | 0.060 |
Why?
|
Risk Factors | 5 | 2022 | 74831 | 0.060 |
Why?
|
Myocardium | 1 | 2018 | 4763 | 0.060 |
Why?
|
Predictive Value of Tests | 3 | 2019 | 15390 | 0.060 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 618 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10730 | 0.060 |
Why?
|
Cluster Analysis | 1 | 2011 | 2720 | 0.060 |
Why?
|
Radiography | 1 | 2015 | 6917 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4563 | 0.060 |
Why?
|
Survival Rate | 1 | 2018 | 12787 | 0.060 |
Why?
|
Logistic Models | 1 | 2018 | 13261 | 0.050 |
Why?
|
Colloids | 1 | 2022 | 122 | 0.050 |
Why?
|
Up-Regulation | 1 | 2011 | 4136 | 0.050 |
Why?
|
Prospective Studies | 5 | 2019 | 54795 | 0.050 |
Why?
|
Heart | 1 | 2014 | 4417 | 0.050 |
Why?
|
Odds Ratio | 1 | 2013 | 9647 | 0.050 |
Why?
|
Boston | 1 | 2014 | 9337 | 0.050 |
Why?
|
RNA, Neoplasm | 1 | 2004 | 745 | 0.050 |
Why?
|
Polymers | 2 | 2022 | 1621 | 0.040 |
Why?
|
Oxides | 1 | 2022 | 402 | 0.040 |
Why?
|
Immunoglobulin G | 1 | 2012 | 4527 | 0.040 |
Why?
|
Pilot Projects | 1 | 2014 | 8732 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3794 | 0.040 |
Why?
|
Whole Blood Coagulation Time | 1 | 2019 | 29 | 0.040 |
Why?
|
Coronary Artery Bypass | 1 | 2009 | 2185 | 0.040 |
Why?
|
Anticoagulants | 3 | 2021 | 4862 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2011 | 18972 | 0.040 |
Why?
|
Oscillometry | 1 | 2019 | 151 | 0.040 |
Why?
|
Viscosity | 1 | 2019 | 334 | 0.040 |
Why?
|
Rheology | 1 | 2019 | 348 | 0.040 |
Why?
|
Resuscitation | 1 | 2022 | 679 | 0.040 |
Why?
|
T-Lymphocytes | 3 | 2004 | 10262 | 0.040 |
Why?
|
Age Factors | 1 | 2014 | 18375 | 0.040 |
Why?
|
Epitopes | 1 | 2004 | 2523 | 0.030 |
Why?
|
Elasticity | 1 | 2019 | 652 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2009 | 3850 | 0.030 |
Why?
|
Interleukin-2 | 1 | 2004 | 1896 | 0.030 |
Why?
|
Time Factors | 2 | 2019 | 40066 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2002 | 1250 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39180 | 0.030 |
Why?
|
Perioperative Period | 1 | 2017 | 251 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2004 | 1998 | 0.030 |
Why?
|
Cohort Studies | 1 | 2018 | 41631 | 0.030 |
Why?
|
Phenotype | 2 | 2011 | 16706 | 0.030 |
Why?
|
Gels | 1 | 2014 | 419 | 0.030 |
Why?
|
Cell Shape | 1 | 2014 | 372 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2009 | 9522 | 0.030 |
Why?
|
Prognosis | 1 | 2013 | 29899 | 0.030 |
Why?
|
Cell Differentiation | 3 | 2020 | 11641 | 0.020 |
Why?
|
Injections | 1 | 2014 | 839 | 0.020 |
Why?
|
Acrylic Resins | 1 | 2012 | 131 | 0.020 |
Why?
|
Blood Platelets | 1 | 2021 | 2463 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2014 | 723 | 0.020 |
Why?
|
Chondrogenesis | 1 | 2012 | 238 | 0.020 |
Why?
|
Acrylamides | 1 | 2012 | 257 | 0.020 |
Why?
|
Immunotherapy | 2 | 2004 | 4752 | 0.020 |
Why?
|
Ascorbic Acid | 1 | 2012 | 657 | 0.020 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2012 | 637 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2002 | 12769 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2004 | 6356 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2004 | 5442 | 0.020 |
Why?
|
Melanoma | 1 | 2004 | 5690 | 0.020 |
Why?
|
Osteogenesis | 1 | 2012 | 1282 | 0.010 |
Why?
|
Interferon-gamma | 2 | 2004 | 3159 | 0.010 |
Why?
|
MART-1 Antigen | 1 | 2004 | 62 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2014 | 8102 | 0.010 |
Why?
|
Lung | 1 | 2022 | 10031 | 0.010 |
Why?
|
Young Adult | 2 | 2022 | 59852 | 0.010 |
Why?
|
Viral Matrix Proteins | 1 | 2004 | 192 | 0.010 |
Why?
|
Solubility | 1 | 2004 | 1078 | 0.010 |
Why?
|
CD40 Ligand | 1 | 2004 | 528 | 0.010 |
Why?
|
Granulocytes | 1 | 2004 | 549 | 0.010 |
Why?
|
Isoantigens | 1 | 2004 | 562 | 0.010 |
Why?
|
Interleukin-12 | 1 | 2004 | 579 | 0.010 |
Why?
|
Electroporation | 1 | 2002 | 238 | 0.010 |
Why?
|
Antigen-Presenting Cells | 1 | 2004 | 962 | 0.010 |
Why?
|
Incidence | 1 | 2017 | 21478 | 0.010 |
Why?
|
Pregnancy | 1 | 2018 | 30248 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2004 | 6109 | 0.010 |
Why?
|
Aged | 1 | 2009 | 171050 | 0.010 |
Why?
|
Adult | 2 | 2022 | 222974 | 0.010 |
Why?
|
Animals | 2 | 2020 | 168731 | 0.010 |
Why?
|
Middle Aged | 1 | 2009 | 222903 | 0.010 |
Why?
|
Transfection | 1 | 2002 | 5744 | 0.010 |
Why?
|
Vaccines | 1 | 2002 | 841 | 0.010 |
Why?
|
Antigens, CD | 1 | 2004 | 4020 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2004 | 3691 | 0.010 |
Why?
|
Mice | 1 | 2020 | 81792 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2004 | 5302 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2004 | 3593 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2004 | 3110 | 0.010 |
Why?
|
Cell Line | 1 | 2002 | 15542 | 0.000 |
Why?
|
Signal Transduction | 1 | 2004 | 23589 | 0.000 |
Why?
|
Concepts
(193)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(31)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_